Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
HCC38
TNBC
Basal B
PD 98059
MEK
MAPK
11850.159
uM
160.78440
1000.00000
0.5303 -0.5897 0.4263 0.1253
0.6880
1.9270
HCC38
TNBC
Basal B
PD 98059
MEK
MAPK
10578.136
uM
inf
25.79330
0.5933 0.5928 4.8756 0.0532
0.8707
1.5577
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
10578.1
uM
8.71610
17.04880
-0.9474 -1.0000 1.6375 0.3665
0.8880
1.6202
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
7468.093
uM
3.78550
10.17590
-0.7786 -1.0000 1.1110 0.2905
0.8947
1.4007
HCC38
TNBC
Basal B
PD173074
FGFR1/3
RTK
10418.093
uM
3.53430
7.85550
-0.9028 -1.0000 1.3755 0.2763
0.9686
0.9872
HCC38
TNBC
Basal B
PD184352
MEK
MAPK
11850.155
uM
inf
inf
0.9060 0.9060 0.0000 0.0877
0.0000
2.1810
HCC38
TNBC
Basal B
PD184352
MEK
MAPK
11850.155
uM
inf
inf
0.9060 0.9060 0.0000 0.0877
0.0000
2.1810
HCC38
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7469.095
uM
inf
inf
0.9298 0.9298 0.0000 -0.0029
0.3387
1.8946
HCC38
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
10418.095
uM
inf
inf
0.7496 0.7496 0.0000 0.1450
0.4999
1.1425
HCC38
TNBC
Basal B
Pemetrexed
TYMS/DHFR/GARFT
TYMS
7468.095
uM
inf
10.77520
0.9056 0.9344 4.7741 0.0327
0.6580
1.4474
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
10418.065
uM
inf
inf
0.7550 0.7550 0.0000 0.0403
0.2487
0.9401
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
7468.065
uM
inf
inf
0.8447 0.8447 0.0000 0.0735
0.5698
1.5219
HCC38
TNBC
Basal B
PS-1145
IKK
NFKB
7469.065
uM
inf
61.95750
0.9161 0.9150 0.8933 0.0080
0.6490
2.0006
HCC38
TNBC
Basal B
Purvalanol A
CDK1
CDK
7468.067
uM
inf
14.3580
0.7721 0.8436 4.9310 0.0226
0.7090
1.3847
HCC38
TNBC
Basal B
Purvalanol A
CDK1
CDK
7469.067
uM
12.43870
9.76010
0.2405 0.3513 5.0000 0.1616
0.9455
2.0639
HCC38
TNBC
Basal B
QNZ
NFkB
NFKB
7468.096
uM
0.21256
0.03213
0.4325 0.4677 1.4500 0.2940
0.9839
1.5683
HCC38
TNBC
Basal B
Ribavirin
15351.211
uM
inf
inf
0.7443 0.7443 0.0000 0.0613
-0.0247
1.0866
HCC38
TNBC
Basal B
Ro 32-0432
PKC
PKC
10578.142
uM
inf
inf
0.9560 0.9560 0.0000 0.0618
0.0539
1.8112
HCC38
TNBC
Basal B
SB-3CT
MMP2/9
MMP
10578.144
uM
inf
inf
0.7826 0.7826 0.0000 0.0668
0.4813
1.6376
HCC38
TNBC
Basal B
SB-3CT
MMP2/9
MMP
11850.144
uM
80.42810
339.98370
0.4351 -0.9939 0.7593 0.0989
0.9433
1.9379
HCC38
TNBC
Basal B
Selumetinib
MEK
MAPK
11850.155
uM
inf
inf
0.9277 0.9277 0.0000 0.0704
0.0489
2.1810
HCC38
TNBC
Basal B
Sigma A6730
AKT
AKT
10578.141
uM
15.45350
25.19440
-0.8095 -1.0000 2.2476 0.2500
0.9606
1.5679
HCC38
TNBC
Basal B
Sigma A6730
AKT
AKT
11850.158
uM
10.3470
20.16870
-0.7560 -1.0000 1.6460 0.2433
0.9906
1.9855
HCC38
TNBC
Basal B
Sirolimus
MTOR
MTOR
9028.068
uM
inf
inf
-0.4589 -0.4589 0.0000 0.6455
0.4044
1.2240
HCC38
TNBC
Basal B
Sirolimus
MTOR
MTOR
7854.068
uM
0.44605
993.87220
-0.0308 -0.8745 0.1312 0.4907
0.6533
1.3310